CAMBRIDGE, Mass., Oct. 28, 2008 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced the promotion of Adelene Q. Perkins to president and chief business officer. In this position, Ms. Perkins will continue to have responsibility for all of Infinity's business functions, including corporate and product strategy, business development, finance, organizational development and human resources, investor and public relations, legal, and facilities and operations.
